Skip to content
Valuentum

Valuentum

Exclusive Analysis for the Discerning Investor

  • Membership
  • Home
  • Newsletters
  • High Yield
  • Exclusive
  • Stocks
  • Dividends
  • Advisers
  • Valuations
  • About Us

Life Technologies Unveils One-Day Genome Sequencer Product; Shares Jump 8% to Our $47 Fair Value Estimate

January 10, 2012 by Brian Nelson

Please click on the link below to access our 16-page report on Life Tech (LIFE):

/20110928_1

Supplemental Information:

<< Bloomberg’s News Report

<< About the Ion Proton Sequencer

Categories Member Articles Tags LIFE
WebMD Cuts Through Our Fair Value Estimate; Falls Almost 30% Today
Lululemon Raises Guidance; Our Valuation Remains Unchanged
 
 
Forgot Password

Newsletters/Portfolios

Valuentum's Dividend Growth Newsletter Portfolio

Valuentum's Best Ideas Newsletter Portfolio

Order the Exclusive Publication!

Order the High-Yield Dividend Newsletter!

Dividend Cushion

Efficacy

Calculation

Dividend-Adjusted Leverage

White Paper

Stock Screens

How to Filter Data in Microsoft Excel Like a Pro

Download Weekly Stock Screener (xls)

The Quarterly DataScreener

Products & Tools

Financial Advisor (GOLD LEVEL) Publications

Order Value Trap

Order Value Trap, second edition

Value Trap

Order Paperback Copy

BookLife Review

BlueInk Review

Foreword Review

Readers' Favorite Review

Axiom Bronze

Praise

The Buying Index, VBI

Value and Momentum Within Stocks, Too (2017)

The Case for the Valuentum Style of Investing (2012)

Investing's Odd Couple: Value and Momentum (2013)

Stock-Selection Methodology, the Valuentum Buying Index (2011)

Why Valuentum Buying Index Ratings Matter (2014)

Footer

  • Home
  • About Us
  • Disclaimer
  • Advertise
  • Careers

Footer 2

  • Contact
  • Logout
  • Join Now
  • Privacy Policy
  • Terms & Conditions
© Copyright 2011-2026 Valuentum Securities Inc - Built with GeneratePress